Parham Sadeghipour
A5053506294- Venous Thromboembolism Diagnosis and Management
- Acute Myocardial Infarction Research
- COVID-19 Clinical Research Studies
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Aortic Disease and Treatment Approaches
- COVID-19 and healthcare impacts
- Cardiac Imaging and Diagnostics
- Congenital Heart Disease Studies
- Long-Term Effects of COVID-19
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Ischemic Stroke Management
- Aortic aneurysm repair treatments
- Central Venous Catheters and Hemodialysis
- Infective Endocarditis Diagnosis and Management
- Cardiac Arrhythmias and Treatments
- Coronary Artery Anomalies
- Cardiac Structural Anomalies and Repair
- Vascular Procedures and Complications
- Lipoproteins and Cardiovascular Health
- Peripheral Artery Disease Management
- Cardiac Health and Mental Health
- Blood Coagulation and Thrombosis Mechanisms
- Cardiovascular Function and Risk Factors
Iran University of Medical Sciences
2016-2025
Shaheed Rajaei Cardiovascular Medical and Research Center
2016-2025
Hospital General Universitario de Albacete
2024
Hospital Universitario La Paz
2024
Firoozgar General Hospital
2020-2023
Faculty of 1000 (United States)
2023
Lymphatic Education & Research Network
2023
British Heart Foundation
2022
University of Leeds
2022
Leeds Teaching Hospitals NHS Trust
2022
Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic prophylaxis.To evaluate effects intermediate-dose vs standard-dose prophylactic anticoagulation among COVID-19 admitted intensive care unit (ICU).Multicenter randomized trial a 2 × factorial design performed 10 academic centers Iran comparing (first hypothesis) and statin therapy matching placebo (second hypothesis; not this article) adult ICU Patients...
The optimal treatment of intermediate-high-risk pulmonary embolism (PE) remains unknown.To assess the effect conventional catheter-directed thrombolysis (cCDT) plus anticoagulation vs monotherapy in improving echocardiographic measures right ventricle (RV) to left (LV) ratio acute PE.The Catheter-Directed Thrombolysis Anticoagulation Patients with Acute Intermediate-High-Risk Pulmonary Embolism (CANARY) trial was an open-label, randomized clinical patients PE, conducted 2 large...
Microvascular and macrovascular thrombotic events are among the hallmarks of coronavirus disease 2019 (COVID-19). Furthermore, exuberant immune response is considered an important driver pulmonary extrapulmonary manifestations COVID-19. The optimal management strategy to prevent thrombosis in critically-ill patients with COVID-19 remains unknown.
Abstract Background Thrombotic complications are considered among the main extrapulmonary manifestations of coronavirus disease 2019 (COVID-19). The optimal type and duration prophylactic antithrombotic therapy in these patients remain unknown. Methods This article reports final (90-day) results Intermediate versus Standard-dose Prophylactic anticoagulation In cRitically-ill pATIents with COVID-19: An opeN label randomized controlled trial (INSPIRATION) study. Patients COVID-19 admitted to...
Abstract Objective To assess the effect of statin treatment versus placebo on clinical outcomes in patients with covid-19 admitted to intensive care unit (ICU). Design INSPIRATION/INSPIRATION-S was a multicenter, randomized controlled trial 2×2 factorial design. Results for anticoagulation randomization have been reported previously. double blind atorvastatin are here. Setting 11 hospitals Iran. Participants Adults aged ≥18 years ICU. Intervention Atorvastatin 20 mg orally once daily...
Background and Objective: The HEART pathway serves as a tool for predicting major adverse cardiac events (MACE) among patients presenting with acute chest pain, aiding in the early discharge of low-risk reducing unnecessary investigations. This study aimed to evaluate physician–nurse reliability investigate efficacy predict 3-month MACE pain. Methods: We conducted prospective on 97 experiencing A team 3 professionals, nurse, cardiology resident, attending physician, performed risk...
The main objective was to evaluate the cost-effectiveness of various medical therapy combinations in managing chronic coronary syndrome (CCS) Iran, based on real-world and patient-level data. A cost-utility analysis employing a Markov model conducted using data from retrospective cohort study. study healthcare setting focusing primary secondary care. Patients with CCS were included Numbers entering completing reported, clear definitions selection, entry exclusion criteria. All recommended...
Mohsen Maadani, Soudabeh Shafiee Ardestani, Farnaz Rafiee, Kiara Rezaei-Kalantari, Parham Rabiee, Yasmin Mohtasham Kia, Ali Zahedmehr, Bahram Mohebbi, Armin Elahifar, Ehsan Khalilipur, Ata Firouzi, and Sadeghipour. Vasc Specialist Int 2025;41:. https://doi.org/10.5758/vsi.240103
Air pollution is associated with excess thrombotic and cardiovascular events. However, clinical outcomes trials evaluating interventions to mitigate such adverse events in patients atherosclerotic diseases (ASCVD) are lacking. This a single-center, open-label, feasibility randomized controlled trial (RCT) conducted adult documented ASCVD. Participants were hybrid strategy consisting of an educational flashcard, cell phone text message alerts on polluted days stay indoors, use KN95 masks if...
The coronavirus disease 2019 (COVID-19) pandemic has prompted the further virtualization of medical education. satisfaction level specific users such as cardiology residents with virtual education can augment its quality; hence, significance a valid and reliable questionnaire to obtain feedback is needed. This study aimed design measure validity reliability for during COVID-19 pandemic.In this cross-sectional study, self-administered was developed by faculty members Rajaie Cardiovascular...